Prospective Randomised Trial With Regard to Maternal Morbidity after 1
g Cefotiam Antibiotics are widley applied as a prophylaxis in emergen
cy Caesarean section. In our institution we used to infuse 2 g cefotia
m, after cord clamping during emergency Casearean section. The current
trial was conducted to prove whether a reduced dosage of 1 g is suffi
cient. From September 1994 to November 1995 ninety-nine women were enr
olled into the study. After the decision for emergency Caesarean secti
on had been made, the patient's informed consent was obtained. Exclusi
on criteria were any situation requiring antibiotic treatment or suspe
cted chorioamnionitis with antibiotic therapy started during delivery.
After randomisation, 53 patients received 1 g and 46 patients 29 cefo
tiam. The clinical courses including events such as endometritits, mas
titis, urinary tract infection or anything else, were evaluated prospe
ctively. On the first and last day of the post partum period a blood c
ell count and CRP determination were performed. In the 1 g group of pa
tients no increase of clinical infections could be found. Neither the
infection parameter nor the average or maximum temperatures differed i
n either group. In the 1 g group 11 patients had temperatures above 37
,9 degrees C, whereas there were 16 patients in the 29 group with such
temperatures. This difference was not statistically significant. The
incidence of clinically relevant infections is low in both groups. The
1 g dosage of cefotiam during emergency Caesarean section appears equ
ivalent to the 2 g dosage.